Gliomatosis cerebri: a consensus summary report from the Second International Gliomatosis cerebri Group Meeting, June 22-23, 2017, Bethesda, USA

J Neurooncol. 2018 Oct;140(1):1-4. doi: 10.1007/s11060-018-2938-x. Epub 2018 Jul 11.


Gliomatosis cerebri (GC) is an aggressive glioma characterized by an invasive growth pattern and a dismal prognosis. The low incidence and non-specific symptoms at presentation pose unique challenges for early diagnosis and disease-specific research. There is no standard of care for the treatment of patients with a GC phenotype. Understanding the biology of this entity is a critical step in determining effective treatments. Toward this end, the Second International GC Group convened at National Institutes of Health, Bethesda on June 22nd-23rd 2017. This paper summarizes the main conclusions and recommendations for research priorities to fight this fatal condition.

Keywords: Consensus; Gliomatosis cerebri; Meeting; Second International Gliomatosis cerebri Meeting 2017.

MeSH terms

  • Brain Neoplasms* / diagnosis
  • Brain Neoplasms* / epidemiology
  • Brain Neoplasms* / therapy
  • Consensus
  • Epigenesis, Genetic
  • Humans
  • National Institutes of Health (U.S.)
  • Neoplasms, Neuroepithelial* / diagnosis
  • Neoplasms, Neuroepithelial* / epidemiology
  • Neoplasms, Neuroepithelial* / therapy
  • Prognosis
  • United States